Approval In Canada Expands The Market For The Candela QuadraLASE

Main Category: Dermatology
Also Included In: Regulatory Affairs / Drug Approvals
Article Date: 06 May 2009 - 6:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  


Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:not yet rated


Candela Corporation (NASDAQ: CLZR) announced that Health Canada has cleared the new QuadraLASE™ advanced CO2 fractional laser for distribution in Canada. Launched at the American Academy of Dermatology Annual Meeting in March 2009, the QuadraLASE is changing the way practitioners are looking at fractional CO2 laser treatments. With a unique combination of the proven performance of a CO2 laser and an innovative scanning device, the QuadraLASE is an effective solution for popular aesthetic treatments such as skin rejuvenation*, skin tightening/wrinkle reduction**, uneven tone and texture, and acne scarring.

President and CEO, Gerard E. Puorro, commented, "Candela's customers in the United States, Europe and Australia are looking at fractional CO2 in a new way and embracing the QuadraLASE as a total rejuvenation system. In addition, they are reporting that the QuadraLASE is a great option for patients who want fast results and better looking skin without the need for multiple treatments."

Mr. Puorro added, "We are excited that the expansion of the QuadraLASE into Canada means that practitioners will have more choices and greater flexibility to meet their individual practice needs. Numerous physicians that have used other fractional technologies have reported that they are very satisfied with the results that they are getting with the QuadraLASE without the cost of consumables."

Mr. Puorro continued, "Additionally, our customers in other parts of the world are finding that the QuadraLASE is the ideal complement to our lasers including the AlexTriVantage®, our multi-wavelength Q-switched laser, and the Vbeam® Perfecta for best-in-class, anti-aging treatments."

About QuadraLASE

The new QuadraLASE fractional laser features proprietary QuadraSCAN™ technology, which reduces heat build-up in the skin, resulting in increased patient comfort. Candela QuadraLASE offers performance, versatility and value in a fractional CO2 laser. In addition, the system is engineered to fit the needs of every aesthetic practice offering:

Value with no disposables - keeping long term operating costs down.
Choice of QS 300 micron and QD 180 micron handpieces, providing true variable depth ablation.
Elegant design and small footprint minimizing the need for space.
Renowned Candela after-the-sale support.

For more information please visit http://www.quadralase.com or call 800-733-8550 ext. 247.

* Skin rejuvenation by reduction of diffuse redness and pigmentation.
** Skin tightening through wrinkle reduction.

QuadraLASE and QuadraSCAN are trademarks, and Candela is a registered trademark of Candela Corporation.

Source
Candela Corporation

Article adapted by Medical News Today from original press release.
Visit our dermatology section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
QuadraLASE. "Approval In Canada Expands The Market For The Candela QuadraLASE." Medical News Today. MediLexicon, Intl., 6 May. 2009. Web.
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/149083.php>

APA
QuadraLASE. (2009, May 6). "Approval In Canada Expands The Market For The Candela QuadraLASE." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/149083.php.

Please note: If no author information is provided, the source is cited instead.




Dermatology

Most Popular Articles



Follow Our Dermatology News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Dermatology Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »